Search results for "Lipids"

showing 10 items of 2228 documents

Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats

2007

Rats with carnitine deficiency due to trimethylhydrazinium propionate (mildronate) administered at 80 mg/100 g body weight per day for 10 days developed liver steatosis only upon fasting. This study aimed to determine whether the transient steatosis resulted from triglyceride accumulation due to the amount of fatty acids preserved through impaired fatty acid oxidation and/or from up-regulation of lipid exchange between liver and adipose tissue. In liver, mildronate decreased the carnitine content by approximately 13-fold and, in fasted rats, lowered the palmitate oxidation rate by 50% in the perfused organ, increased 9-fold the triglyceride content, and doubled the hepatic very low density …

Malemedicine.medical_specialtyVery low-density lipoproteintissu adipeuxAdipose tissuerattus rattusBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicinestéatose hépatiqueCarnitineInternal medicinemedicineAnimalsLipolysisCarnitineRats Wistarpathologie animaleMolecular BiologyBeta oxidationlipide030304 developmental biologychemistry.chemical_classification0303 health sciencesTriglycerideFatty AcidsFatty acidCell Biologyfoiemedicine.diseaseLipidsRats[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry Molecular Biology/Biomolecules [q-bio.BM]Fatty LiverLipoproteins LDLLipoprotein LipaseEndocrinologyAdipose TissueGene Expression RegulationLiverchemistryHepatocytesRATSteatosisTriolein030217 neurology & neurosurgerymedicine.drug
researchProduct

Association between alcoholism and symptom expression, patient symptom goals, and clinical response in advanced cancer patients

2019

Aim: The aim of this study was to determine the influence of alcoholism on symptom expression, personalized symptom goal (PSG) and patient goal response (PGR), and patient global impression (PGI) in advanced cancer patients. Methods: This was a secondary analysis of an international multicenter study. Advanced cancer patients who had a history of alcohol dependence positive, according to CAGE (cut down, annoy, guilt, eye-opener), were selected. Thirty patients (3.45%) were CAGE-positive. This sample was matched with 30 patients with similar characteristics who were CAGE-negative. Patients rated symptom intensity by using the Edmonton Symptom Assessment Score (ESAS) at admission (T0) and the…

Malemedicine.medical_specialtyWeaknessPalliative careNauseaPain medicine03 medical and health sciences0302 clinical medicineNeoplasmsStatistical significanceInternal medicinemental disordersHumansMedicine030212 general & internal medicineAgedGlobal impressionbusiness.industryMinimal clinically important differenceAlcohol dependencePatients’ goalAdvanced cancerAdvanced cancer patientAlcoholismOncology030220 oncology & carcinogenesisClinical responseSymptom burdenFemalelipids (amino acids peptides and proteins)Symptom Assessmentmedicine.symptombusinessGoals
researchProduct

Influence of lipids on blood and plasma viscosity.

2014

Amparo Vayaa,∗, Cristina Gimeneza, Rafael Alisb,c, Julian Muradoa and Oscar Fustera aHemorheology and Haemostasis Unit, Service of Clinical Pathology, La Fe University Hospital, Valencia, Spain bResearch Universitary Institute “Dr. Vina Giner”, Molecular and Mitochondrial Medicine, Catholic University of Valencia “San Vicente Martir”, Valencia, Spain cFaculty of Medicine, Catholic University of Valencia “San Vicente Martir”, Valencia, Spain

Malemedicine.medical_specialtybiologyPhysiologybusiness.industryHematologybiology.organism_classificationUniversity hospitalLipidsPhysiology (medical)Family medicineHemorheologymedicineHumansFemaleCardiology and Cardiovascular MedicinePlasma viscositybusinessValenciaClinical hemorheology and microcirculation
researchProduct

Liver carbohydrate and lipid metabolism of insulin-deficient mice is altered by trans-10, cis-12 conjugated linoleic acid.

2009

Feeding mice the trans-10, cis-12 (t10c12) conjugated linoleic acid (CLA) isomer is associated with lipodystrophy, insulin resistance, hyperinsulinemia, and liver steatosis. It has been hypothesized that CLA-induced liver steatosis is the result of increased hepatic lipogenesis stimulated by high insulin levels. We studied the effects of a 12-d t10c12CLA treatment (1 g/100 g diet) on liver carbohydrate and lipid metabolism in control and streptozotocin (STZ)-injected mice. STZ mice were characterized by insulin deficiency, hypertriglyceridemia, and depletion of liver triglyceride and glycogen. Remarkably, feeding t10c12CLA to diabetic mice (STZ-CLA) normalized these variables. Reconstitutio…

Malemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentMedicine (miscellaneous)BiologyDiabetes Mellitus Experimentalchemistry.chemical_compoundMiceInsulin resistanceInternal medicinemedicineAnimalsLinoleic Acids ConjugatedNutrition and DieteticsGlycogenGlucokinaseInsulinFatty livernutritional and metabolic diseasesLipid metabolismmedicine.diseaseLipid MetabolismMice Inbred C57BLEndocrinologychemistryGene Expression RegulationLiverGlycogenesisLipogenesisBody CompositionCarbohydrate Metabolismlipids (amino acids peptides and proteins)The Journal of nutrition
researchProduct

Lipoprotein lipase-facilitated uptake of LDL is mediated by the LDL receptor

2007

LPL mediates the uptake of lipoproteins into different cell types independent of its catalytic activity. The mechanism of this process and its physiological relevance are not clear. Taking into account the importance of the endothelial barrier for lipoprotein uptake, in vitro studies with primary aortic endothelial cells from wild-type and low density lipoprotein receptor (LDLR)-deficient (LDLR(-/-)) mice were performed. Addition of LPL almost doubled the uptake of LDL into wild-type cells. However, there was virtually no LPL-mediated change of LDL uptake into LDLR(-/-) cells. Upregulation of LDLR by lipoprotein-deficient serum/lovastatin in wild-type cells resulted in a 7-fold increase of …

Malemedicine.medical_specialtyendotheliumQD415-436BreedingBiochemistrylipidschemistry.chemical_compoundMiceEndocrinologyChylomicron remnantInternal medicinemedicineAnimalscardiovascular diseasesMuscle SkeletalCells CulturedLipoprotein lipaseCholesteroldigestive oral and skin physiologyEndothelial Cellsfood and beveragesnutritional and metabolic diseasescholesterolBiological TransportCell BiologyDietary FatsDietLipoproteins LDLMice Inbred C57BLLipoprotein LipaseEndocrinologychemistryBiochemistryReceptors LDLLow-density lipoproteinLDL receptortransportFemaleProteoglycanslipids (amino acids peptides and proteins)Lovastatinatherosclerosislow density lipoproteinmedicine.drugChylomicronLipoproteinJournal of Lipid Research
researchProduct

Portulaca oleracea reduces triglyceridemia, cholesterolemia, and improves lecithin: cholesterol acyltransferase activity in rats fed enriched-cholest…

2014

Abstract Purpose The effects of Portulaca oleracea ( Po ) lyophilized aqueous extract were determined on the serum high-density lipoproteins (HDL 2 and HDL 3 ) amounts and composition, as well as on lecithin: cholesterol acyltansferase (LCAT) activity. Methods Male Wistar rats ( n  = 12) were fed on 1% cholesterol-enriched diet for 10 days. After this phase, hypercholesterolemic rats (HC) were divided into two groups fed the same diet supplemented or not with Portulaca oleracea ( Po -HC) (0.5%) for four weeks. Results Serum total cholesterol (TC) and triacylglycerols (TG), and liver TG values were respectively 1.6-, 1.8-, and 1.6-fold lower in Po -HC than in HC group. Cholesterol concentrat…

Malemedicine.medical_specialtyfood.ingredientHypercholesterolemiaPharmaceutical SciencePortulacaPortulacaLecithinCholesterol DietaryPhosphatidylcholine-Sterol O-Acyltransferasechemistry.chemical_compoundfoodInternal medicineDrug DiscoverymedicineAnimalsRats WistarTriglyceridesHypolipidemic AgentsPharmacologychemistry.chemical_classificationHypertriglyceridemiaChromatographybiologyCholesterolPlant ExtractsReverse cholesterol transportbiology.organism_classificationPlant LeavesEnzymeEndocrinologyCholesterolComplementary and alternative medicinechemistryLiverLecithin—cholesterol acyltransferasebiology.proteinMolecular Medicinelipids (amino acids peptides and proteins)Composition (visual arts)Acyl groupPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Analysis of left ventricular volumes and function: a multicenter comparison of cardiac magnetic resonance imaging, cine ventriculography, and unenhan…

2013

Background: Contrast echocardiography improves accuracy and reduces interreader variability on left ventricular (LV)functional analyses inthe settingof two-dimensional (2D) echocardiography. Theneedfor contrast imaging using three-dimensional (3D) echocardiography is less defined. The aim of this multicenter study was to define the accuracy and interreader agreement of unenhanced and contrast-enhanced 2D and 3D echocardiography for the assessment of LV volumes and ejection fraction (EF). Methods: A multicenter, open-label study was conducted including 63 patients, using intrasubject comparisons to assess the agreement of unenhanced and contrast-enhanced 2D and 3D echocardiography as well as…

Malemedicine.medical_specialtymedia_common.quotation_subjectEchocardiography Three-DimensionalSulfur HexafluorideContrast MediaMagnetic Resonance Imaging CineSensitivity and SpecificityVentricular Dysfunction LeftCardiac magnetic resonance imagingInternal medicinemedicineContrast (vision)HumansRadiology Nuclear Medicine and imagingSingle-Blind MethodRadionuclide VentriculographyPhospholipidsmedia_commonObserver VariationEjection fractionmedicine.diagnostic_testbusiness.industryReproducibility of ResultsThree dimensional echocardiographyStroke VolumeOrgan SizeConfidence intervalEuropeContrast echocardiographyCardiologyFemaleCardiology and Cardiovascular MedicinebusinessCardiac magnetic resonanceNuclear medicine3d echocardiographyJournal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
researchProduct

MRI as the new reference standard in quantifying liver steatosis: the need for international guidelines.

2012

We read with great interest the paper by Raptis et al 1 regarding the quantification of liver steatosis by chemical-shift MRI. Chemical-shift imaging takes advantage of the difference in resonance frequency between water and fat (more precisely methylene, the most abundant group in triglycerides) to differentiate them. The dual-echo (in-phase/out-of-phase) MR technique used by the authors and derived from one of their previously published papers2 neglects T2* decay and assumes that the signal difference is due to fat–water interference alone.3 Yet, liver iron …

Malemedicine.medical_specialtymedicine.diagnostic_testbusiness.industryFatty liverGastroenterologyMagnetic resonance imagingmedicine.diseaseLipidsMagnetic Resonance ImagingFatty LiverLiver steatosismedicineLiver ironAnimalsHumansFemaleRadiologybusinessNuclear medicineReference standardsGut
researchProduct

Real-world study: Escalating targeted lipid-lowering treatment with PCSK9-inhibitors and lipoprotein apheresis.

2018

INTRODUCTION Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition with monoclonal antibodies has complemented the armamentarium of lipid-lowering therapy (LLT) before the final step of commencing chronic lipoprotein apheresis (LA). Data are scarce on patients who, after escalation of LLT with PCSK9 antibodies, have commenced chronic LA or PCSK9 antibody treatment during ongoing long-term LA. PATIENTS AND METHODS In this study, a cohort of 110 patients with established atherosclerotic cardiovascular disease (ASCVD) due to hypercholesterolemia or concomitant lipoprotein(a)-hyperlipoproteinemia, who received PCSK9 antibodies for the first time during routine care, were consecutivel…

Malemedicine.medical_specialtymedicine.drug_classLipoproteinsHypercholesterolemia030204 cardiovascular system & hematologyMonoclonal antibodyGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansEnzyme InhibitorsAdverse effectbiologybusiness.industryPCSK9PCSK9 InhibitorsAntibodies MonoclonalHematologyGeneral MedicineLipoprotein(a)Cholesterol LDLMiddle AgedAtherosclerosisCombined Modality TherapyLipidsDiscontinuationConcomitantCohortbiology.proteinBlood Component RemovalFemaleAntibodyProprotein Convertase 9business030215 immunologyLipoprotein(a)Journal of clinical apheresis
researchProduct

Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.

1995

A randomized double-blind study was carried out with gemfibrozil (600 mg b.i.d.) vs placebo in 20 patients (twelve males and eight females, age 52 +/- 3 years, BMI 24.2 +/- 0.4) suffering from primary hypertriglyceridemia (Fredrickson's type IV). Each group was treated for a 12 week period with gemfibrozil (n = 10) or placebo (n = 10) patients) in a double-blind fashion. Total cholesterol, HDL-cholesterol (HDL-C) and its subfractions (HDL2-C and HDL3-C), blood glucose, Apolipoproteins A1 and B, fibrinogen, plasminogen, factor VII, t-PA:Ag and PAI activity pre- and post-venous occlusion (VO) were determined. In the gemfibrozil-treated group a significant decrease of total cholesterol and tri…

Malemedicine.medical_specialtymedicine.medical_treatmentLipoproteinsFibrinogenchemistry.chemical_compoundDouble-Blind MethodInternal medicineFibrinolysismedicineGemfibrozilHumansTriglyceridesApolipoproteins BHypertriglyceridemiaTriglycerideApolipoprotein A-Ibusiness.industryCholesterolFibrinolysisHypertriglyceridemiaReverse cholesterol transportCholesterol HDLFibrinogenPlasminogenHematologyGeneral MedicineFactor VIIMiddle Agedmedicine.diseaseEndocrinologyCholesterolchemistryTissue Plasminogen Activatorlipids (amino acids peptides and proteins)FemaleGemfibrozilbusinessLipoproteinmedicine.drugBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct